Takeda Pharmaceutical
TAK
#398
Rank
HK$441.11 B
Marketcap
HK$139.63
Share price
-1.55%
Change (1 day)
20.97%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2025 (TTM): HK$4.40

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$4.40. a decrease over its 2024 EPS that were of HK$2.38.

EPS history for Takeda Pharmaceutical from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$1.79-25.03%
2024HK$2.38-60.3%
2023HK$6.0026.77%
2022HK$4.73-44.4%
2021HK$8.51722.5%
2020HK$1.03-79.14%
2019HK$4.96-43.73%
2018HK$8.8270.24%
2017HK$5.1845.47%
2016HK$3.56-158.86%
2015-HK$6.05-217.99%
2014HK$5.13-34.43%
2013HK$7.825.17%
2012HK$7.43-49.61%
2011HK$14.75-6.27%
2010HK$15.7436.82%
2009HK$11.50-28.28%
2008HK$16.0424.96%
2007HK$12.839.24%
2006HK$11.753.21%
2005HK$11.38-6.29%
2004HK$12.1518.8%
2003HK$10.2330.39%
2002HK$7.8452.45%
2001HK$5.141.77%
2000HK$5.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.22 1,884.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.64 1,211.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65 142.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.22 2,453.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.17 267.94%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$57.22 1,201.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.51 571.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$31.40-814.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$6.10 38.73%๐Ÿ‡ฎ๐Ÿ‡ณ India